Shanner Laura
John Dossetor Health Ethics Centre, University of Alberta, Edmonton, Alberta, Canada.
Health Law Rev. 2002;11(1):62-6.
Stem cell policy discussions frequently confuse embryonic and fetal sources of stem cells, and label untested, non-reproductive cloning as "therapeutic." Such misnomers distract attention from significant practical and ethical implications: accelerated research agendas tend to be supported at the expense of physical risks to women, theological implications in a multi-faith community, informed consent for participation in research, and treatment decisions altered by unrealistic expectations.
